Media Mentions
2008
Barbara Jones was mentioned in the September 26 issue of The Boston Business Journal in an article regarding Pro-Pharmaceuticals Inc., the latest biotech company to possibly face a cash crunch. Ms. Jones explained that there has been a significant slow down in the PIPE market this year, which many biotechs rely upon for funding. As a result, companies without commercialized products are finding it more difficult to secure funding than in the past.
Barbara A. Jones, Corporate, Life Sciences & Medical Devices, Private Equity
Barbara A. Jones was quoted in a May 19 article published by Boston Business Journal regarding Acusphere Inc., a specialty pharmaceutical company, and their current cash crunch while they wait for FDA approval on Imagify, a blood imaging agent. Ms. Jones noted that many companies awaiting FDA approval often find it difficult to obtain funding, but eventually find success through a variety of strategies.
Barbara A. Jones, Corporate, Life Sciences & Medical Devices
